Tropical Disease Foundation
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Alberto, Edison
NCT06015282: The Celljuvant Study: a Phase 3 Immunogenicity and Safety Study of AQIVc Vaccine in Adults Aged 50 Years and Older

Active, not recruiting
3
7741
Europe, Canada, US, RoW
Investigational aQIVc, licensed QIV1, licensed QIV2
Seqirus
Influenza, Human
03/24
01/25
NCT03932682 / 2018-001857-29: Efficacy Study With QIVc in Pediatric Subjects

Completed
3
5723
Europe, RoW
QIVc, Flucelvax Quadrivalent, Comparator
Seqirus
Influenza, Human
11/23
02/24
NCT06087640: A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Active, not recruiting
3
35800
Europe, RoW
aQIV or aTIV, Fluad Tetra/Quadrivalent or Fluad, QIV or TIV
Seqirus
Influenza, Human
11/26
12/26
NCT05463419: A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose.

Completed
2/3
5860
RoW
PIKA COVID-19 vaccine, Inactivated Covid-19 vaccine
Yisheng Biopharma (Singapore) Pte. Ltd.
Covid-19 Vaccine
12/23
04/24
NCT05457946: Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series

Not yet recruiting
2/3
1438
NA
LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains)
LG Chem
Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type B Infection
09/25
09/25
Achivar, Rolando
No trials found

Download Options